PD-L1 positive

Clinical trials for PD-L1 positive explained in plain language.

Never miss a new study

Get alerted when new PD-L1 positive trials appear

Sign up with your email to follow new studies for PD-L1 positive, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 2

Promising combo may keep rare melanoma at bay

Disease control Recruiting now

This study tests whether adding the immunotherapy drug sintilimab to standard chemotherapy can help prevent a rare type of skin cancer (mucosal melanoma) from coming back after surgery. About 220 adults with PD-L1-positive, completely removed tumors will be randomly assigned to g…

Matched conditions: PD-L1 POSITIVE

Phase 2 • Sponsor: The First Hospital of Jilin University • Aim: Disease control

Last updated Sep 05, 2026 00:00 UTC

PD-L1 positive

Get alerted when new PD-L1 positive trials appear

Promising combo may keep rare melanoma at bay